Anke H Maitland-van der Zee
Overview
Explore the profile of Anke H Maitland-van der Zee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
2866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vonk S, Terheggen-Lagro S, Haarman E, Hashimoto S, Maitland-van der Zee A, Mathot R, et al.
J Cyst Fibros
. 2025 Mar;
PMID: 40089408
Background: The clinical efficacy of elexacaftor-tezacaftor-ivacaftor (ETI) in children with cystic fibrosis (cwCF) is variable; some respond, while others do not or have side effects. The pharmacokinetics (PK) of ETI...
2.
Baalbaki N, Slob E, Kazer S, I Abdel-Aziz M, Bogaard H, Golebski K, et al.
Allergy
. 2025 Mar;
PMID: 40084919
An estimated 10% of coronavirus disease (COVID-19) survivors suffer from persisting symptoms referred to as long COVID (LC), a condition for which approved treatment options are still lacking. This systematic...
3.
Blankestijn J, Baalbaki N, Beijers R, Cornelissen M, Wiersinga W, I Abdel-Aziz M, et al.
Int J Mol Sci
. 2025 Feb;
26(4).
PMID: 40004244
An estimated 10% of COVID-19 survivors have been reported to suffer from complaints after at least three months. The intestinal microbiome has been shown to impact long COVID through the...
4.
van Poelgeest J, Shahbazi Khamas S, Hallawa A, DAlessandro C, DAlessandro C, Ferreira R, et al.
J Breath Res
. 2025 Feb;
19(2).
PMID: 39999477
Chronic obstructive pulmonary disease (COPD) exacerbations significantly contribute to disease progression, hospitalizations, and decreased quality of life. Early detection of exacerbations through non-invasive methods, such as exhaled volatile organic compounds...
5.
Martin-Gonzalez E, Perez-Garcia J, Herrera-Luis E, Martin-Almeida M, Kebede-Merid S, Hernandez-Pacheco N, et al.
Allergy
. 2025 Feb;
PMID: 39907155
Background: Asthma exacerbations (AEs) represent the major contributor to the global asthma burden. Although genetic and environmental factors have been associated with AEs, the role of epigenetics remains uncovered. Objective:...
6.
Alizadeh Bahmani A, I Abdel-Aziz M, Hashimoto S, Bang C, Brandstetter S, Corcuera-Elosegui P, et al.
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857673
: Metered-dose inhalers (MDIs) and dry powder inhalers (DPIs) are common inhaled corticosteroid (ICS) inhaler devices. The difference in formulation and administration technique of these devices may influence oral cavity...
7.
Jacobs J, Beekers I, Verkouter I, Richards L, Vegelien A, Bloemsma L, et al.
PLOS Digit Health
. 2025 Jan;
4(1):e0000464.
PMID: 39787064
Precision, or personalised medicine has advanced requirements for medical data management systems (MedDMSs). MedDMS for precision medicine should be able to process hundreds of parameters from multiple sites, be adaptable...
8.
Baalbaki N, Verbeek S, Bogaard H, Blankestijn J, van den Brink V, Cornelissen M, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767601
Background/objectives: A significant number of COVID-19 cases experience persistent symptoms after the acute infection phase, a condition known as long COVID or post-acute sequelae of COVID-19. Approved prevention and treatment...
9.
Slob E, Vijverberg S, Ruffles T, Noij L, Biermann J, Brouwer A, et al.
Allergy
. 2024 Dec;
PMID: 39723595
Background: Long-acting beta2-agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially...
10.
Meys R, Franssen F, van t Hul A, Bakke P, Caruso M, Dahlen B, et al.
Health Qual Life Outcomes
. 2024 Dec;
22(1):109.
PMID: 39707320
Rationale: Knowledge about the clinical importance of patient-reported outcome measures (PROMs) in severe asthma is limited. Objectives: To assess whether and to what extent asthma exacerbations affect changes in PROMS...